The net sale for the company is reported at Rs. 890.34 crore for the quarter ended March 2011. For the same period last fiscal, net sale stood at Rs. 991.83 crore.
For the year ended march 2011, jubilant life sciences posted consolidated net sales at 3433.4 crore compared to Rs. 3791.13 crore for the same period last fiscal.
Similarly, consolidated net profit for the twelve months period ended March 2011 is reported at Rs. 229.72 crore compared to Rs. 421.46 crore posted during the same period last fiscal.
For the financial year 2011, the company business was driven by 16% increase in the volume growth across various product offerings.
The company reported the total debt at Rs. 3884 crore as on fiscal year ending March 2011. Company also reported the outstanding Foreign Currency Convertible Bonds (FCCBs) at USD 142 million together with accrued interest of USD 60 million payable by March 19, 2011.
The company is supposed to meet this obligation by using Rs. 1046 crore of cash balance. This cash balance is held in the form of bank deposits and liquid funds.
Jubilant life science has demerged its polymer and agriculture business into separate entity, Jubilant Industries.
So, the data published by company for last two fiscals are not comparable in practical sense.